-

Diabetes Research Institute Foundation Launches National Public Service Announcement to Highlight Silent Impact of Diabetes and Quest for a Cure

MIAMI--(BUSINESS WIRE)--The Diabetes Research Institute Foundation (DRIF), a not-for-profit corporation funding critical research at the Diabetes Research Institute (DRI), today launched a national public service announcement (PSA) that sheds light on the hidden daily impact of type 1 diabetes (T1D) and the urgent need for a cure.

Titled “Our Best Shot,” the PSA offers an intimate glimpse into the reality of T1D through the eyes of children and adults living with this autoimmune disease, and encourages audiences to visit diabetesresearch.org to learn more about the most promising research toward a cure that could end diabetes forever.

Watch the PSA here: https://youtu.be/u-tHTmH9ekk.

“This PSA captures what drives our mission: to cure and prevent T1D and ensure that no diagnosis stands in the way of a full and healthy life,” said Michael J. Burton, chief executive officer of the DRIF. “By spotlighting how the DRIF’s best shot at a cure is the best shot at life for people living with T1D, we’re showing the public what’s really at stake – from constantly monitoring blood sugar levels to the daily anxiety of potential complications. Through our cutting-edge research, we are confident a cure will be found to reverse T1D and restore the body’s ability to produce insulin naturally.”

We don’t just hope for a cure, we’re building it. At the University of Miami Miller School of Medicine, the DRI's integrated research teams are pioneering breakthrough approaches in immune therapies, cell transplantation, and regenerative medicine. Each discovery brings us closer to the ultimate goal: restoring natural insulin production in people with T1D and eliminating the threat of this insidious disease once and for all.

About the Diabetes Research Institute and Foundation

The DRI is a comprehensive, multidisciplinary research center and recognized world leader in the field. By working in close collaboration with cure-focused partners in real-time across the globe, we can accelerate the pace of discovery and ensure that the best ideas are quickly translated into actionable clinical research.

The DRI Foundation (DRIF), a 501(c)(3) not-for-profit corporation, is the organization of choice for those who are serious, passionate and committed to curing and preventing diabetes. Our mission – to provide the DRI with the funding necessary to advance critical research – is a testament to the belief that tomorrow is not soon enough to change the lives of people living with diabetes.

Donors make it possible for our researchers to pursue bold ideas and keep critical projects moving forward. With limited funding available through traditional channels and growing competition for research grants, private support has never been more important. It fills the gaps and helps accelerate the most promising paths to a cure.

For more information, please visit www.diabetesresearch.org or call 800-321-3437.

Contacts

Media Contact:
Michael Myers, Chief Communications Officer
Diabetes Research Institute Foundation
(847) 208-6920 or mmyers@drif.org

Diabetes Research Institute and Foundation


Release Versions

Contacts

Media Contact:
Michael Myers, Chief Communications Officer
Diabetes Research Institute Foundation
(847) 208-6920 or mmyers@drif.org

More News From Diabetes Research Institute and Foundation

Regenerating the Pancreas: DRI Scientists Demonstrate Diabetes Reversal in Preclinical Model Using Small Peptide

MIAMI--(BUSINESS WIRE)--In major diabetes research news just published in Nature Communications, scientists at the Diabetes Research Institute (DRI) at the University of Miami have shown that a small peptide, called THR-123, can trigger regeneration of insulin-producing beta cells in the pancreas, restoring normal blood sugar levels in pre-clinical experimental models. This regenerative effect, achieved without cell transplantation, offers new hope for treating insulin-dependent diabetes throug...

Diabetes Research Institute Welcomes Dr. Dirk Homann to Esteemed Team of Scientists Leading Cure-Focused Diabetes Research

MIAMI--(BUSINESS WIRE)--As one of the largest and most comprehensive research centers dedicated to curing diabetes, the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine (UM-DRI) today announced that Dirk Homann, MD, PhD, has joined its prestigious team of scientific researchers as a newly appointed Professor of Medicine, specializing in the immunology of type 1 diabetes (T1D). Dr. Homann brings nearly two decades of experience as a trained physician and imm...

Diabetes Research Institute Foundation Partners with Instacart to Launch a Virtual Storefront to Support the Health and Well-Being of People Living with Diabetes

HOLLYWOOD, Fla.--(BUSINESS WIRE)--The Diabetes Research Institute Foundation (DRIF), an organization dedicated to developing and rapidly applying the most promising research to treat and cure people living with diabetes, today announced a partnership with Instacart Health, an initiative of Instacart, the leading grocery technology company in North America, that aims to improve nutrition security, make healthy choices easier for consumers, and expand the role that food can play in improving heal...
Back to Newsroom